Cargando…
SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021
We conducted a nationwide retrospective cohort study to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection among recipients of 4 different vaccines in South Korea. Age-adjusted breakthrough infection rate per month was highest for Janssen (42.6/100,000 popul...
Autores principales: | Yi, Seonju, Choe, Young June, Kim, Jia, Kim, Yoo-Yeon, Kim, Ryu Kyung, Jang, Eun Jung, Lim, Do Sang, Byeon, Hye Ryeon, Lee, Sangwon, Park, Eonjoo, Kim, Seung-Jin, Park, Young-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888240/ https://www.ncbi.nlm.nih.gov/pubmed/35202529 http://dx.doi.org/10.3201/eid2803.212210 |
Ejemplares similares
-
Impact of national Covid-19 vaccination Campaign, South Korea
por: Yi, Seonju, et al.
Publicado: (2022) -
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
por: Jang, Eun Jung, et al.
Publicado: (2022) -
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
por: Kim, Yoo-Yeon, et al.
Publicado: (2023) -
SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
por: Yi, Seonju, et al.
Publicado: (2021) -
Effectiveness of A Fourth Dose of COVID-19 mRNA Vaccine in the Elderly Population During the Omicron BA.2 and BA.5 Circulation: A Nationwide Cohort Study in Korea (K-COVE)
por: Park, Seon Kyeong, et al.
Publicado: (2023)